Subtopic Deep Dive
Postpartum Hemorrhage Prevention
Research Guide
What is Postpartum Hemorrhage Prevention?
Postpartum hemorrhage prevention involves pharmacological interventions like tranexamic acid and oxytocin, alongside non-pharmacological bundle protocols, to reduce primary and secondary PPH incidence in maternal care.
Researchers focus on randomized trials evaluating tranexamic acid timing and uterotonics efficacy (Shakur-Still et al., 2017; 1378 citations). Bundle protocols integrate early detection with treatments in low-resource settings (Gallos et al., 2023; 174 citations). Over 10 key trials since 2010 inform global guidelines, with 5000+ citations total.
Why It Matters
Postpartum hemorrhage causes 27% of maternal deaths worldwide, making prevention critical in low-resource areas (Shakur-Still et al., 2017). Tranexamic acid reduces mortality by 31% when given early (Gayet-Ageron et al., 2017). Bundle protocols cut severe PPH risk by 60% in vaginal deliveries (Gallos et al., 2023), enabling scalable interventions in sub-Saharan Africa trials.
Key Research Challenges
Timing of Tranexamic Acid
Delayed administration reduces antifibrinolytic efficacy in severe hemorrhage (Gayet-Ageron et al., 2017; 384 citations). Meta-analysis of 40,138 patients shows optimal windows under 3 hours. Balancing prophylaxis risks in cesareans remains unresolved (Sentilhes et al., 2021).
Fibrinogen Depletion Detection
Early biomarkers like Fibtem predict progression but require viscoelastometry access (Collins et al., 2014; 236 citations). Trials link low fibrinogen to transfusion needs (Collins et al., 2017; 202 citations). Low-resource settings lack point-of-care tools.
Uterotonic Comparative Efficacy
Network meta-analysis ranks carbetocin and ergometrine-oxytocin combinations, but head-to-head trials are scarce (Gallos et al., 2018; 226 citations). Heat-stable agents suit tropical climates. Implementation varies by setting.
Essential Papers
Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial
Haleema Shakur‐Still, Ian Roberts, Bukola Fawole et al. · 2017 · The Lancet · 1.4K citations
Prevention and Management of Postpartum Haemorrhage
H Mousa, J Blum, Abou El Senoun et al. · 2016 · BJOG An International Journal of Obstetrics & Gynaecology · 737 citations
Accurate documentation of a delivery with PPH is essential. DebriefingAn opportunity to discuss the events surrounding the obstetric haemorrhage should be offered to the woman (possibly with her bi...
Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients
Angèle Gayet‐Ageron, David Prieto‐Merino, Katharine Ker et al. · 2017 · The Lancet · 384 citations
UK NIHR Health Technology Assessment programme, Pfizer, BUPA Foundation, and J P Moulton Charitable Foundation (CRASH-2 trial). London School of Hygiene & Tropical Medicine, Pfizer, UK Department o...
The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
Haleema Shakur‐Still, Diana Elbourne, Metin Gülmezoglu et al. · 2010 · Trials · 323 citations
Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery
Loı̈c Sentilhes, Marie Victoire Sénat, Maëla Le Lous et al. · 2021 · New England Journal of Medicine · 254 citations
BACKGROUND: Prophylactic administration of tranexamic acid has been associated with reduced postpartum blood loss after cesarean delivery in several small trials, but evidence of its benefit in thi...
Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study
Peter W. Collins, Graeme Lilley, D. Bruynseels et al. · 2014 · Blood · 236 citations
Key Points Fibtem is an early and rapidly available biomarker for predicting progression of moderate to severe postpartum hemorrhage. Fibtem was predictive of need for blood transfusion and invasiv...
Labor and delivery guidance for COVID-19
Rupsa C. Boelig, Tracy A. Manuck, Emily A. Oliver et al. · 2020 · American Journal of Obstetrics & Gynecology MFM · 231 citations
Reading Guide
Foundational Papers
Start with Shakur-Still et al. (2010; 323 citations) for WOMAN protocol design, then Collins et al. (2014; 236 citations) for Fibtem biomarker validation, as they establish tranexamic and coagulation basics.
Recent Advances
Study Gallos et al. (2023; 174 citations) for bundle efficacy, Sentilhes et al. (2021; 254 citations) for cesarean prophylaxis, and Collins et al. (2017; 202 citations) for fibrinogen trials.
Core Methods
Core techniques include double-blind RCTs (Shakur-Still et al., 2017), network meta-analysis (Gallos et al., 2018), viscoelastometry (Collins et al., 2014), and individual patient-data meta-analysis (Gayet-Ageron et al., 2017).
How PapersFlow Helps You Research Postpartum Hemorrhage Prevention
Discover & Search
Research Agent uses searchPapers and exaSearch to find WOMAN trial citations (Shakur-Still et al., 2017), then citationGraph reveals 1378 downstream studies on tranexamic acid timing. findSimilarPapers expands to bundle protocols like Gallos et al. (2023).
Analyze & Verify
Analysis Agent applies readPaperContent to extract hazard ratios from Shakur-Still et al. (2017), verifies via CoVe against GRADE criteria for RCTs, and runs PythonAnalysis on meta-analysis data from Gayet-Ageron et al. (2017) for survival curves.
Synthesize & Write
Synthesis Agent detects gaps in low-resource bundle adoption from Gallos et al. (2023), flags contradictions in uterotonic rankings (Gallos et al., 2018). Writing Agent uses latexEditText, latexSyncCitations for trial comparisons, and latexCompile for protocol flowcharts.
Use Cases
"Run meta-analysis on tranexamic acid timing in PPH prevention trials"
Analysis Agent → runPythonAnalysis (pandas on extracted data from Shakur-Still et al., 2017 and Gayet-Ageron et al., 2017) → matplotlib forest plots of HRs with statistical outputs.
"Draft LaTeX review of uterotonic network meta-analysis"
Synthesis Agent → gap detection on Gallos et al. (2018) → Writing Agent latexEditText + latexSyncCitations (10 papers) + latexCompile → compiled PDF with ranked efficacy table.
"Find code for Fibtem biomarker models in PPH studies"
Research Agent → paperExtractUrls (Collins et al., 2014) → paperFindGithubRepo → githubRepoInspect → R script for viscoelastometry simulation.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (250+ PPH papers) → citationGraph → GRADE grading → structured report on tranexamic bundles. DeepScan analyzes 7 steps: readPaperContent (Shakur-Still et al., 2017) → CoVe verification → Python hazard ratios. Theorizer generates hypotheses on fibrinogen-viscoelastometry integration from Collins et al. (2017).
Frequently Asked Questions
What defines postpartum hemorrhage prevention?
It encompasses pharmacological (tranexamic acid, uterotonics) and bundle interventions to avert primary/secondary PPH exceeding 500mL vaginal or 1000mL cesarean loss.
What are key methods in PPH prevention?
Randomized trials test tranexamic acid prophylaxis (Sentilhes et al., 2021), viscoelastometric-guided fibrinogen (Collins et al., 2017), and early bundle detection (Gallos et al., 2023).
What are landmark papers?
WOMAN trial (Shakur-Still et al., 2017; 1378 citations) shows tranexamic reduces mortality; Gallos et al. (2023; 174 citations) validates bundles.
What open problems exist?
Optimal tranexamic timing in prophylaxis (Gayet-Ageron et al., 2017), fibrinogen access in low-settings (Collins et al., 2014), and uterotonic superiority in diverse populations (Gallos et al., 2018).
Research Maternal and fetal healthcare with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Postpartum Hemorrhage Prevention with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Maternal and fetal healthcare Research Guide